Introduction

Botulism is a neuroparalytic disease caused by the bacteria Clostridium botulinum. It is an anaerobic organism, naturally found in soil, dust and aquatic sediments.^{1 2} Botulinum produces the most potent neurotoxins, characterised as a category A biological threat agent. People may be exposed to botulinum neurotoxins by foodborne botulism caused by the ingestion of food, intestinal colonisation which usually occurs in infants and results from ingestion of spores, followed by colonisation of the gut and toxin production in the body. The other category is wound botulism, in which the toxin is produced in vivo (inside the living body) after a localised tissue infection. The signs and symptoms are the same for all three epidemiological types of botulism. Wound botulism represents a distinct clinical entity with unique considerations for wound care. This article explores the pathogenesis of wound botulism, risk factors, challenges, and wound management.

What conditions favour botulinum growth and toxin production in wounds?

Whilst foodborne contamination is the most common route for botulism infection, wounds provide another pathway for the progression of wound botulism. The vegetative C. botulinum produces neurotoxins that can enter the bloodstream through the wound, leading to the characteristic flaccid paralysis associated with botulism. C. botulinum spores require specific conditions within a wound to germinate, grow, and produce toxins. They are as follows:

Anaerobic environment

These anaerobic bacteria cannot survive without the presence of oxygen. Deep wounds, especially those with weakened tissue or necrotic areas are suitable for spore germination and bacterial growth.

Nutrients

Any pathogen requires nutrients for growth, likewise, C. botulinum gets nutrients from dead tissues and blood present in the wound.

pH level

Compared to other pathogens, botulinum can grow in a wide pH range however, a neutral or slightly alkaline environment (pH 7-8) is optimal for toxin production.

Improper wound care

In situations where wound cleaning or removal of dead cells/debris is inadequate, a decrease in competing microbes can create a more favourable environment for C. botulinum growth. It can grow within a relatively wide temperature range (10°C-50°C), which is close to the human body temperature.

Pathophysiology

The botulinum neurotoxin is a 150 kDa (kiloDalton) protein, composed of a heavy chain (100 kDa) and a light chain (50 kDa).³ There are eight distinct serotypes of botulinum neurotoxin, A (BoNT/A) through H (BoNT/H) with toxin subtypes A, B, E, F, G, and H. The toxin enters the bloodstream, once released, BoNT migrates via transcytosis across the mucosal barrier into the circulation. The BoNT travels and binds with the presynaptic nerve terminals of neuromuscular junctions, and this promotes endocytosis. The light chain part of the toxin targets the SNAP-25, VAMP, or syntaxin polypeptide (group of protein forming peptide chains) complex, where the BoNT blocks presynaptic acetylcholine (a chemical that is released in the gaps of nerves) release and inhibits muscle contraction, causing flaccid paralysis.

Clinical features, signs and symptoms of botulism

The onset of symptoms in naturally occurring cases of botulism is between 2 hours and 8 days after ingestion, depending on the type and dose of the toxin. Symptoms may peak 48 hours after inoculation (entering the body). The primary clinical signs are similar in all botulism infections. They include symmetrical cranial neuropathies, which refer to weakness or paralysis of the cranial nerves, which control functions like swallowing, speaking, and facial expressions. Symptoms may include:

• Difficulty swallowing (dysphagia)
• Slurred speech (dysarthria)
• Drooping eyelids (ptosis)
• Blurred or double vision
• Dry mouth (xerostomia)

Less common, some individuals may experience nausea and vomiting, abdominal cramps or constipation. As symptoms progress, muscle weakness spreads downwards, affecting the arms, legs, and eventually the muscles responsible for breathing (the respiratory muscles). Life-threatening complications include respiratory failure, and this requires immediate medical attention.

How might wound botulism present differently from other types of botulism?

Wound botulism is typically slower with a more variable onset of symptoms, and may take several days, even weeks, to develop toxin production in the wound. In some cases, there may be signs of infection or inflammation around the wound which wouldn't be present in foodborne botulism. These are the main differentiating factors for wound botulism compared to other types of botulism. The neurological symptoms of muscle weakness, cranial nerve palsies, and difficulty breathing are quite similar in all cases. 

What are the potential risk factors for wound contamination?

Wound botulism has a serious morbidity with a 10% mortality rate. Some are at a greater risk of botulism infection due to spore introduction directly into their wounds.⁴

Trauma/ wounds

Patients with weakened areas or open fractures can harbour spores and provide the necessary conditions for toxin production. Deep wounds provide a suitable anaerobic environment for C. botulinum growth. 

Larger wounds offer more space for bacterial colonisation. Conditions such as diabetic foot and venous leg ulcers often have wounds that are slow to heal and therefore create a suitable environment for bacterial growth. In rare cases, inadequately managed surgical site infections can create an anaerobic environment conducive to C. botulinum growth.

Injection/ drug users

Drug abusers are a group of people at great risk due to the practice of sharing needles, using non-sterile injection equipment and injecting into areas with compromised skin integrity. In a study, spores are introduced into the bloodstream by injection prick, using citric acid to dissolve heroin. The presence of high concentrations of citric acid damages the muscles under the skin providing more favourable conditions for bacterial penetration.⁵,^6,7

Other vulnerable populations

People with weakened immune systems due to conditions like HIV/AIDS or particular medications are at higher risk of developing wound infections, including botulism. Occupations with exposure to soil or dust, where spores are commonly found, may increase the risk of wound contamination.

Diagnosis

A thorough evaluation of the patient's medical history, focusing on any wounds or recent injuries, is crucial. The presence of classic neurological symptoms like weakness, cranial nerve palsies (dysphagia, ptosis), and difficulty breathing is highly suggestive of botulism. The absence of fever can further support the suspicion of botulism compared to other infectious causes. 

Unfortunately, no single definitive test exists for wound botulism. However, several laboratory tests can aid in diagnosis. Laboratory confirmation with serum and stool assays for botulinum neurotoxin, stool microscopy for spores, stool cultures, and wound cultures are used in this case. Electromyograms can be used as a supportive presumptive diagnosis based on the history and physical nature of the infected individual.⁸ 

Due to the potential for life-threatening respiratory failure, a high index of suspicion and prompt initiation of diagnostic procedures are crucial. Even if initial tests are inconclusive, starting treatment based on strong clinical suspicion can be life-saving. In some cases, a trial of antitoxin (the specific antibody against botulinum toxin) can be used as a diagnostic tool. If the patient's symptoms improve significantly after receiving antitoxin, it strongly suggests botulism.

Management

A multimodal treatment approach is needed for patient management, right from antitoxin administration, close monitoring, respiratory support and debridement (removal of damaged tissue of foreign objects from a wound)  plus antibiotics. Patients who are known to have pre-existing comorbidities (other existing disease conditions) of respiratory problems must be identified early and the respiratory rate, pulse oximetry, and arterial blood gas measurements should be monitored. ^{9, 10}

Antitoxin therapy

Antitoxin administration is an effective treatment in reducing the severity of symptoms, arresting the progression of paralysis and decreasing the duration of paralysis and dependence on mechanical ventilation. Antitoxin produces serum levels of toxin-type specific antibodies capable of neutralising serum toxin concentrations.¹¹ 

A trivalent (A, B and E) antitoxin administration should take place as soon as possible after clinical findings demonstrative of botulism but it is preferably administered after the appropriate specimens have been collected. The antitoxin administration may cause anaphylaxis reaction, serum sickness and other hypersensitivity reactions, but the risk is low. The antitoxin can be repeated within 24 hours if the patient continues to deteriorate.⁹,¹,²

Wound management

Wound debridement (removal of damaged tissue of foreign objects from a wound) and antibiotic therapy are advocated for following antitoxin administration, it is considered an essential strategy in the management of wound botulism, which includes surgical removal of damaged tissue and necrotic patches (patches of dead cells) followed by specialised dressings that promote the body's natural debridement processes. Following that, regular cleaning plus maintaining balanced moisture which further promotes healing. 

Antibiotic therapy may start with Penicillin G intravenously (IV) or metronidazole 500 mg for penicillin-allergic patients.

The usage of aminoglycosides can be contraindicated in some patients. While botulinum antitoxin, debridement (removal of damaged tissue of foreign objects from a wound) and antibiotic regime address the core aspects of wound botulism, supportive care plays a critical role in preventing complications and promoting patient recovery, including respiratory support, nutritional support, physical therapy, and general supportive care.

Summary

Botulism is a disease that causes nerve damage or paralysis,this is caused by the bacteria Clostridium botulinum. It releases a neurotoxin called botulin which damages or paralyses the nerves, specifically cranial nerves. There are two types of botulism - one is food botulism, which occurs through spore-contaminated food and the other is wound botulism in which spores enter through the wounds of the body. This article detailed symptoms, diagnostic tests, differentiation of symptoms from other diseases and wound hygiene in botulism. Studies show that wound botulism remains rare however, its severe clinical manifestations and burden on healthcare systems highlight the need for ongoing prevention and education efforts. Proper understanding of the epidemiology, clinical signs and symptoms, and outcome of management are essential for developing effective public health strategies and improving patient care.